Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 79

1.

Prescription use behavior among medicare beneficiaries with capped prescription benefits.

Cox ER, Henderson RR.

J Manag Care Pharm. 2002 Sep-Oct;8(5):360-4.

2.

Medicare beneficiaries' management of capped prescription benefits.

Cox ER, Jernigan C, Coons SJ, Draugalis JL.

Med Care. 2001 Mar;39(3):296-301.

PMID:
11242323
3.

Cost-lowering strategies used by medicare beneficiaries who exceed drug benefit caps and have a gap in drug coverage.

Tseng CW, Brook RH, Keeler E, Steers WN, Mangione CM.

JAMA. 2004 Aug 25;292(8):952-60.

PMID:
15328327
5.

Impact of the Medicare modernization act on low-income persons.

Havrda DE, Omundsen BA, Bender W, Kirkpatrick MA.

Ann Intern Med. 2005 Oct 18;143(8):600-8.

PMID:
16230727
6.
7.

Impact of multi-tiered pharmacy benefits on attitudes of plan members with chronic disease states.

Nair KV, Ganther JM, Valuck RJ, McCollum MM, Lewis SJ.

J Manag Care Pharm. 2002 Nov-Dec;8(6):477-91.

8.

Pharmacy students teaching prescribers strategies to lower prescription drug costs for underserved patients.

Stebbins MR, Frear ME, Cutler TW, Lightwood JM, Fingado AR, Lai CJ, Lipton HL.

J Manag Care Pharm. 2013 Sep;19(7):534-41.

9.

Impact of cost sharing on prescription drugs used by Medicare beneficiaries.

Goedken AM, Urmie JM, Farris KB, Doucette WR.

Res Social Adm Pharm. 2010 Jun;6(2):100-9. doi: 10.1016/j.sapharm.2010.03.003. Epub 2010 May 7.

PMID:
20511109
10.
11.

Association between dispensing channel and medication adherence among medicare beneficiaries taking medications to treat diabetes, high blood pressure, or high blood cholesterol.

Iyengar RN, Balagere DS, Henderson RR, LeFrancois AL, Rabbitt RM, Frazee SG.

J Manag Care Spec Pharm. 2014 Aug;20(8):851-61.

12.

Unfilled prescriptions of medicare beneficiaries: prevalence, reasons, and types of medicines prescribed.

Kennedy J, Tuleu I, Mackay K.

J Manag Care Pharm. 2008 Jul-Aug;14(6):553-60.

13.

Trends in the prescription drug plans delivering the Medicare Part D prescription drug benefit.

Brill JV.

Am J Health Syst Pharm. 2007 Aug 1;64(15 Suppl 10):S3-6; quiz S21-S23. Review.

PMID:
17646551
14.

Impact of multitiered copayments on the use and cost of prescription drugs among Medicare beneficiaries.

Gilman BH, Kautter J.

Health Serv Res. 2008 Apr;43(2):478-95. doi: 10.1111/j.1475-6773.2007.00774.x.

15.

Out-of-pocket drug costs and drug utilization patterns of postmenopausal Medicare beneficiaries with osteoporosis.

Conwell LJ, Esposito D, Garavaglia S, Meadows ES, Colby M, Herrera V, Goldfarb S, Ball D, Marciniak M.

Am J Geriatr Pharmacother. 2011 Aug;9(4):241-9. doi: 10.1016/j.amjopharm.2011.04.009. Epub 2011 May 26.

PMID:
21616722
16.

Out-of-pocket health spending by poor and near-poor elderly Medicare beneficiaries.

Gross DJ, Alecxih L, Gibson MJ, Corea J, Caplan C, Brangan N.

Health Serv Res. 1999 Apr;34(1 Pt 2):241-54.

17.

Cost variability of suggested generic treatment alternatives under the Medicare Part D benefit.

Patel RA, Walberg MP, Tong E, Tan F, Rummel AE, Woelfel JA, Carr-Lopez SM, Galal SM.

J Manag Care Spec Pharm. 2014 Mar;20(3):283-90.

18.

Medicare Part D: selected issues for pharmacists and beneficiaries in 2007.

Kilian J, Stubbings J.

J Manag Care Pharm. 2007 Jan-Feb;13(1):59-65. Review.

19.

The role of satisfaction and switching costs in Medicare Part D choices.

Han J, Ko DW, Urmie JM.

Res Social Adm Pharm. 2014 Mar-Apr;10(2):398-407. doi: 10.1016/j.sapharm.2013.06.010. Epub 2013 Aug 27.

PMID:
23988694
20.

Unintended consequences of caps on Medicare drug benefits.

Hsu J, Price M, Huang J, Brand R, Fung V, Hui R, Fireman B, Newhouse JP, Selby JV.

N Engl J Med. 2006 Jun 1;354(22):2349-59.

Supplemental Content

Support Center